As Dallas Annual Approaches….

…something to keep in mind.

This is not aspirational material.

Rather than editorialize, I will let Jack Lewin, chief executive of the American College of Cardiology, do the work for me.  On booths, promotion, and COI:

The “circus element” of the exhibit booths doesn’t unduly influence attendees, Lewin said. “I don’t buy a soft drink just because of the advertising. … I buy it because I like it.”

Yup.

UPDATE:  Follow the money trail:

Several groups said money from drug, device or insurance companies accounted for less than 10 percent of their revenues. The Leukemia & Lymphoma Society [2], for instance, told Grassley that from 2006 to 2009, it received roughly 5 percent of its funding from industry. The American Cancer Society [3] pegged its percentage even lower, at 1.5 percent.

The American College of Obstetricians and Gynecologists [4] reported 8.6 percent; and the American Psychological Association [5], whose members typically can’t prescribe drugs, said it received less than 1 percent.

ProPublica calculated some percentages based on figures the groups reported to Grassley, data on their websites and tax filings.

Among those with a heavier reliance on industry support were the Heart Rhythm Society [6], nearly 50 percent in 2010; the North American Spine Society [7], more than 50 percent in 2009; and American Academy of Allergy, Asthma and Immunology [8], with more than 40 percent in 2008.

Brad Flansbaum

Bradley Flansbaum, DO, MPH, MHM works for Geisinger Health System in Danville, PA in both the divisions of hospital medicine and population health. He began working as a hospitalist in 1996, at the inception of the hospital medicine movement. He is a founding member of the Society of Hospital Medicine and served as a board member and officer. He speaks nationally in promoting hospital medicine and has presented at many statewide meetings and conferences. He is also actively involved in house staff education.

Currently, he serves on the SHM Public Policy Committee and has an interest in payment policy, healthcare market competition, health disparities, cost-effectiveness analysis, and pain and palliative care. He is SHM’s delegate for the AMA House of Delegates.

Dr. Flansbaum received his undergraduate degree from Union College in Schenectady, NY and attended medical school at the New York College of Osteopathic Medicine. He completed his residency and chief residency in Internal Medicine at Long Island Jewish Medical Center in New York. He received his M.P.H. in Health Policy and Management at Columbia University.

He is a political junky, and loves to cook, stay fit, read non-fiction, listen to many genres of music, and is a resident of Danville, PA.

3 Comments

  1. Michael Radzienda on May 6, 2011 at 8:37 am

    Guess he’s not a “no free lunches” subscriber.

  2. Rachel Lovins on May 6, 2011 at 1:08 pm

    If advertising didn’t work, companies wouldn’t use it.

  3. Bill Rifkin on May 15, 2011 at 12:45 pm

    Where does SHM fall in this regard? Certainly lots of pharma adds etc in CME content, resoucre roooms etc.

Leave a Comment